ML-Based AF Treatment Selection System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for atrial fibrillation, such as pulmonary vein isolation (PVI), face challenges in predicting long-term success, especially with incomplete imaging data, which hinders the selection of appropriate ablation approaches and leads to suboptimal treatment outcomes.
Innovation Solution
A computer-implemented method using machine learning (ML) models that analyze anatomical and voltage-related features of the heart to predict the success of PVI treatments, incorporating a 'wisdom of the crowd' approach to overcome data scarcity by leveraging physician recommendations, thereby selecting between PVI only and PVI plus procedures based on patient-specific data.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If pulmonary vein isolation (PVI) only treatment is used, then treatment simplicity is improved, but long-term treatment success rate deteriorates
Solution Approach 1:
The system changes the parameter of treatment selection by using machine learning models to analyze multiple heart features (anatomical, voltage, rhythm) and determine whether a patient requires PVI only or PVI plus treatment, optimizing the treatment approach based on individual patient characteristics rather than applying a uniform simple approach
Solution Approach 2:
The system performs preliminary analysis of heart features and ML model predictions before treatment to identify patients who are likely to fail PVI only treatment, allowing clinicians to plan more comprehensive PVI plus treatments in advance for those high-risk patients
2Reliability
If more comprehensive treatment (PVI plus) is used, then long-term treatment success rate is improved, but treatment complexity increases
Solution Approach 1:
The system applies local quality by tailoring the treatment approach to individual patient characteristics - using PVI only for patients with favorable features and PVI plus for patients with unfavorable features, rather than applying comprehensive treatment to all patients
Solution Approach 2:
The system uses machine learning models to analyze changes in heart parameters (anatomical structure, voltage patterns, rhythm characteristics) to predict treatment outcomes and guide the selection between PVI only and PVI plus treatments
3Ease of operation
If traditional imaging analysis is used, then measurement simplicity is improved, but prediction accuracy of treatment success deteriorates
Solution Approach 1:
The system merges multiple types of heart data (anatomical imaging, voltage mapping, rhythm analysis) into a comprehensive dataset that feeds into machine learning models, combining multiple measurement modalities to achieve superior prediction accuracy
Solution Approach 2:
The machine learning models serve as intermediaries that process and integrate complex multi-dimensional heart features, transforming raw imaging and measurement data into actionable predictions about treatment success probability
4Measurement precision
If machine learning models with multiple heart features are used, then prediction accuracy of treatment success is improved, but data processing complexity increases
Solution Approach 1:
The system segments the complex analysis task into distinct components handled by different machine learning models - one model for anatomical features, another for voltage features, and another for rhythm features, with each model specializing in a specific type of analysis
Data Source
AI summary
The presently disclosed subject matter includes computer methods and computer systems that enable to select and provide a suitable treatment for AF patients that increases the likelihood of long-term amelioration of AF conditions, and thereby enhances treatment of AF patients. The disclosure provides methods and systems for analysis of the condition of AF patients and the tailoring of personalized treatment regimens based on various AF features obtained from the patients, and the determination of a treatment selected from at least PVI only and PVI plus. To overcome technical difficulties resulting from scarcity of data a machine learning model that is trained using physician recommendation rather than observed treatment outcome is disclosed.